This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why It is Appropriate to Retain Roper Stock Right Now
by Zacks Equity Research
ROP gains from solid momentum across its segments, accretive acquisitions and shareholder-friendly policies.
DXC vs. EPAM: Which Stock Is the Better Value Option?
by Zacks Equity Research
DXC vs. EPAM: Which Stock Is the Better Value Option?
Here's Why You Should Add Roper Stock to Your Portfolio Now
by Zacks Equity Research
ROP gains from solid momentum across its segments, accretive acquisitions and shareholder-friendly policies.
Amdocs (DOX) Down 0.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Amdocs (DOX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Epam (EPAM) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
DXC or EPAM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DXC vs. EPAM: Which Stock Is the Better Value Option?
Here's How Much You'd Have If You Invested $1000 in Epam a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Nutanix (NTNX) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Nutanix (NTNX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
What Makes Epam (EPAM) a New Buy Stock
by Zacks Equity Research
Epam (EPAM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
If You Invested $1000 in Epam a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Can Q3 Earnings Beat & Strong FY24 View Lift the EPAM Stock?
by Zacks Equity Research
EPAM Systems' third-quarter 2024 results benefit from strong top and bottom-line performances, driven by modest growth across its business segments.
Epam (EPAM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Epam (EPAM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Epam (EPAM) Just Overtook the 200-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?
Epam (EPAM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 15.56% and 1.47%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Etsy Q3 Earnings Miss Estimates, Stock Gains on Revenue Beat
by Zacks Equity Research
ETSY Q3 earnings decline y/y. Stock gains despite a weak guidance.
DXC or EPAM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DXC vs. EPAM: Which Stock Is the Better Value Option?
EPAM Expands With First Derivative Buyout: What Should Investors Do?
by Zacks Equity Research
Epam Systems expands its AI capabilities in the financial space with the acquisition of First Derivative.
Should You Invest in the Invesco S&P 500 Equal Weight Technology ETF (RSPT)?
by Zacks Equity Research
Sector ETF report for RSPT
If You Invested $1000 in Epam a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Implied Volatility Surging for EPAM Systems (EPAM) Stock Options
by Zacks Equity Research
Investors need to pay close attention to EPAM Systems (EPAM) stock based on the movements in the options market lately.
Is Invesco S&P 500 Equal Weight Technology ETF (RSPT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPT
Epam (EPAM) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Epam (EPAM) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EPAM Systems (EPAM) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
EPAM Systems' (EPAM) second-quarter 2024 results reflect the negative impacts of a slowdown in IT spending in the ongoing uncertain macroeconomic environment.
Epam (EPAM) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Epam (EPAM) delivered earnings and revenue surprises of 8.41% and 0.62%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Epam (EPAM) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?